Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP

Jairo R Temerozo1, Rafael Joaquim, Eduardo G Regis

  • 1Laboratory on Thymus Research, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro, Brazil.

Plos One
|July 3, 2013
PubMed

Insights

Neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) reduce HIV-1 replication in macrophages. These findings suggest VIP, PACAP, and their receptors as potential therapeutic targets for HIV-1 infection.

Area of Science:

  • Immunology
  • Virology
  • Neuroendocrinology

Background:

  • Macrophages are key in HIV-1 pathogenesis, continuously producing the virus.
  • Host factors significantly influence HIV-1 replication within macrophages.
  • Neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) affect macrophage functions via G protein-coupled receptors (VPAC1, VPAC2, PAC1).

Purpose of the Study:

  • To investigate the impact of VIP and PACAP on HIV-1 production by macrophages.
  • To elucidate the specific receptors mediating the effects of VIP and PACAP on HIV-1 replication.

Main Methods:

  • Treatment of macrophages with VIP and PACAP.
  • Assessment of HIV-1 production levels.
  • Utilized receptor antagonists and specific agonists for VPAC1, VPAC2, and PAC1.
  • Measured secretion of β-chemokines (CCL3, CCL5) and cytokine IL-10.
  • Neutralization assays for secreted factors.

Main Results:

  • VIP and PACAP synergistically or additively decrease HIV-1 production in macrophages.
  • VIP's inhibitory effect is mediated by VPAC1/2 receptors; PACAP acts via VPAC1/2 and PAC1.
  • Activation of VPAC2 or PAC1 inhibits HIV-1 production, while VPAC1 activation enhances it.
  • VIP and PACAP upregulate CCL3, CCL5, and IL-10 secretion, which mediate the antiviral effect.

Conclusions:

  • VIP and PACAP exhibit potent antiviral activity against HIV-1 in macrophages.
  • The findings highlight VPAC2 and PAC1 receptors as promising targets for novel HIV-1 therapies.
  • Targeting these neuropeptide-receptor pathways could offer alternative therapeutic strategies for HIV-1 infection.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...